Table 2.
Assessed outcome | Serum PFAS assessed | Timing of PFAS exposure | Outcome | References |
---|---|---|---|---|
Prevalence of testicular cancer | ||||
PFOA PFHxS |
Adulthood | Increased | Frisbee et al. (43) Barry et al. (44) Kirk et al. (1) Vieira et al. (45) Bartell and Vieira (47) |
|
PFHxS | In utero | Increased | Lin et al. (46) | |
Sperm morphology | ||||
PFOS, PFHxS PFOA + PFOS PFOSA |
Adulthood | Decrease in percentage of normal spermatozoa | Toft et al. (35) Joensen et al. (129) Louis et al. (49) |
|
PFOA, PFOS | In utero | No change | Vested et al. (130) | |
Multiple PFOS, PFOA, PFNA, PFHxS |
Adulthood | No change | Joensen et al. (131) Petersen et al. (132) |
|
Sperm count and concentration | ||||
PFOA | In utero | Decrease in sperm count and concentration | Vested et al. (130) | |
PFOS, PFOA, PFNA, PFHxS | Adulthood | No change | Toft et al. (35) Joensen et al. (131) Petersen et al. (132) Raymer et al. (133) |
|
PFOS | In utero | No change | Vested et al. (130) | |
Sperm DNA quality | ||||
Multiple | Adulthood | Increased sperm DNA damage | Governini et al. (134) | |
PFOS, PFOA, PFNA, PFHxS PFHxA |
Adulthood | No change in DNA integrity | Specht et al. (135) Emerce and Cetin (136) |
|
PFOS, PFOA, PFNA, PFHxS | Adulthood | No change in DNA methylation | Leter et al. (137) | |
Semen volume | ||||
PFOS, PFOA, PFNA, PFHxS | Adulthood | No change | Toft et al. (35) Joensen et al. (131) Joensen et al. (129) Vested et al. (130) Petersen et al. (132) Raymer et al. (133) |
|
Sperm motility | ||||
PFOA | Adulthood | Increase | Toft et al. (35) | |
PFOS, PFOA, PFHS | Adulthood | Decrease | Song et al. (78) | |
Multiple PFOS, PFOA, PFNA, PFHxS |
Adulthood | No change | Joensen et al. (131) Joensen et al. (129) Petersen et al. (132) Raymer et al. (133) |
|
PFOA, PFOS | In utero | No change | Vested et al. (130) | |
Serum levels of testosterone | ||||
PFHxS | In utero | Increase | Nian et al. (138) | |
PFOS | Adulthood | Decrease | Joensen et al. (131) | |
PFOA, PFOS, PFNA | Adulthood | Decrease | Cui et al. (139) | |
PFOS, PFOA, PFHxS, PFNA | Adulthood | No change | Joensen et al. (129) Petersen et al. (132) Raymer et al. (133) |
|
PFOS, PFOA | In utero | No change | Vested et al. (130) | |
Serum levels of sex hormone binding globulin | ||||
PFOA | Adulthood | Increase | Petersen et al. (132) | |
PFOA, PFOS, PFNA | Adulthood | Decrease | Cui et al. (139) | |
PFOS, PFOA, PFHxS, PFNA | Adulthood | No change | Joensen et al. (129) Joensen et al. (131) Petersen et al. (132) |
|
PFOS, PFOA | In utero | No change | Vested et al. (130) | |
Serum levels of luteinizing hormone | ||||
PFOA, PFOS | Adulthood | Increase | Petersen et al. (132) Raymer et al. (133) |
|
PFOA | In utero | Increase | Vested et al. (130) | |
PFBS, PFHpA | In utero | Decrease | Nian et al. (138) | |
PFOS, PFOA, PFHxS | Adulthood | No change | Joensen et al. (129) Cui et al. (139) |
|
PFOS | In utero | No change | Vested et al. (130) | |
Serum levels of follicle-stimulating hormone | ||||
PFOA | In utero | Increase | Vested et al. (130) | |
PFBS | In utero | Decrease | Nian et al. (138) | |
PFOS, PFOA, PFHxS, PFNA | Adulthood | No change | Joensen et al. (129) Petersen et al. (132) Raymer et al. (133) |
|
PFOS | In utero | No change | Vested et al. (130) |